Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
Basic
5
Ṁ422028
58%
chance
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000and
3.00
1,0003.00Related questions
Related questions
Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
54% chance
Will David Sinclair be regularly taking a SGLT2 inhibitor (canagliflozin, empagliflozin) by the end of 2025?
50% chance
Will Kim Jong Un start taking Ozempic (or any GLP-1) by the end of 2025?
22% chance
Will Bryan Johnson still be regularly taking metformin by EOY 2024?
57% chance
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
75% chance
Will a GLP-1 receptor agonist (Ozempic-like drug) be added to public water supplies in the United States by 2075?
30% chance
Reliable Reporting indicating that more than 3% of Americans are taking GLP-1 agonists in 2024
36% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
33% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance